Vesedaganat: vizsgálatok itt: Kína
116 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
- Where
- Shijiazhuang
- Életkor
- 18 év and over
- People
- 48
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07744932 - 2. fázisTaking peopleGut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
- Where
- Nanjing
- Életkor
- 18 év to 90 év
- People
- 33
- Run by
- Jinling Hospital, China
See details and how to joinNCT07611825 - 2. fázisNot yet taking people in KínaA Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 54
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07741617 - No phaseTaking peopleExpression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 400
- Run by
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT04113486 - 2. fázisNot yet taking people in KínaIpilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
- Where
- Chengdu
- Életkor
- 14 év and over
- People
- 66
- Run by
- West China Hospital
See details and how to joinNCT07715565 - 1. fázisNot yet taking people in KínaNeoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 8
- Run by
- Jian Lin
See details and how to joinNCT07686744 - 1. fázisTaking peopleA Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
- Where
- Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming, Luoyang, Nanchang, Shanghai, Shenyang, Wuhan
- Életkor
- 18 év and over
- People
- 214
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06839105 - 1. fázisTaking peopleTo Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- Hrain Biotechnology Co., Ltd.
See details and how to joinNCT07647744 - 1. fázisTaking peopleA Study of DEG6498 in Participants With Solid Tumors
- Where
- Beijing, Guangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Degron Therapeutics Co.
See details and how to joinNCT07244835 - No phaseTaking peopleRadical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 220
- Run by
- Tianjin Medical University Second Hospital
See details and how to joinNCT07321197 - Korai 1. fázisTaking peopleThe Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07645690 - No phaseTaking peopleStudy on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 110
- Run by
- Tianjin Medical University Second Hospital
See details and how to joinNCT07657325 - 1/2. fázisNot yet taking people in KínaPTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07630363 - 2. fázisNot yet taking people in KínaAnlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy
- Where
- Beijing, Changchun, Changsha, Hangzhou, Kunming, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 144
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07627464 - 2. fázisTaking people68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 70
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06949215 - Korai 1. fázisTaking peopleClinical Application of CAIX-Targeted PET Imaging in Tumors
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 3
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07590310 - No phaseTaking people18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT07557225 - 1. fázisTaking peoplePhase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
- Where
- Guangzhou
- Életkor
- 2 év to 18 év
- People
- 51
- Run by
- Sun Yat-sen University
See details and how to joinNCT07584499 - 2. fázisTaking peopleCD70-targeted immunoPET Imaging of Malignant Cancers
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 300
- Run by
- RenJi Hospital
See details and how to joinNCT06852638 - 2. fázisTaking peoplePerioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 75
- Run by
- Jinling Hospital, China
See details and how to joinNCT07571551 - 1/2. fázisTaking peopleDual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
- Where
- Shenzhen
- Életkor
- 18 év and over
- People
- 36
- Run by
- Beijing Biotech
See details and how to joinNCT07551349 - No phaseTaking peopleCAIX PET/ CT Guided Radiation Therapy in CcRCC.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 70
- Run by
- Peking University First Hospital
See details and how to joinNCT07540260 - 1. fázisTaking peopleIB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 12
- Run by
- Grit Biotechnology
See details and how to joinNCT06819293 - No phaseTaking peopleValidation of RCC Predicting Model With Emulated-target Trial
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 4700
- Run by
- Peking University Third Hospital
See details and how to joinNCT07117227 - 1. fázisNot yet taking people in KínaUCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 21
- Run by
- UTC Therapeutics Inc.
See details and how to joinNCT07500805